
Lucine has the ambition to transform and improve patient’s health. Their main therapeutic area is pain. The product, a digital therapeutic is able to relieve patient’s pain in 5 minutes through active substances allowing an analgesic neurostimulation. Customized, their solution is adapted to each patient thanks to an instantaneous measurement and analysis of the pain by facial, vocal and postural recognition.

Lucine has the ambition to transform and improve patient’s health. Their main therapeutic area is pain. The product, a digital therapeutic is able to relieve patient’s pain in 5 minutes through active substances allowing an analgesic neurostimulation. Customized, their solution is adapted to each patient thanks to an instantaneous measurement and analysis of the pain by facial, vocal and postural recognition.
Sector: Digital therapeutics for pain
Headquarters: Bordeaux, France
Employee count: 16
Notable event: Entered judicial receivership in July 2023; assets acquired December 2023
Pain management
Healthcare / Digital Therapeutics
≈ € / $6.5M
Reported participants include Kurma Partners and Bpifrance